- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 34.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 33.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 28.35M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$36.7K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$688.47K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $21.48M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $22.31M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $21.34M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $20.76M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.73M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.5M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.54M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.75M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $31.02M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $31.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.17M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.04M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.65M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.22M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.67M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.17M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $4.25M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $3.58M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $17.11M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $18.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $21.36M |
| Revenue | Q1 2026 · Mar 31, 2025 | $22.28M |